These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15300131

  • 21. The next agent of terror? Understanding smallpox & its implications for prehospital crews.
    Brocato CE, Miller GT.
    JEMS; 2002 Mar; 27(3):44-50, 52-5. PubMed ID: 11913182
    [Abstract] [Full Text] [Related]

  • 22. The OSHA lowdown on occupational exposure to bloodborne pathogens.
    Gile TJ.
    MLO Med Lab Obs; 2001 Jun; 33(6):14-20; quiz 22-3. PubMed ID: 11424285
    [No Abstract] [Full Text] [Related]

  • 23. From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
    JAMA; 2001 Nov 14; 286(18):2226-32. PubMed ID: 11757528
    [No Abstract] [Full Text] [Related]

  • 24. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 May 15; 47(RR-7):1-33. PubMed ID: 9603630
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Postexposure prophylaxis after nonoccupational HIV exposure: clinical, ethical, and policy considerations.
    Lurie P, Miller S, Hecht F, Chesney M, Lo B.
    JAMA; 1998 Nov 25; 280(20):1769-73. PubMed ID: 9842953
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Postexposure Prophylaxis After Possible Anthrax Exposure: Adherence and Adverse Events.
    Nolen LD, Traxler RM, Kharod GA, Kache PA, Katharios-Lanwermeyer S, Hendricks KA, Shadomy SV, Bower WA, Meaney-Delman D, Walke HT.
    Health Secur; 2016 Nov 25; 14(6):419-423. PubMed ID: 27898235
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [HIV post exposure prophylaxis therapy - the experience of two major AIDS centers].
    Elbirt D, Levy I, Asher I, Mahlev-Guri K, Rosenberg-Bezalet S, Litachevsky S, Radian-Sade S, Sthoeger Z.
    Harefuah; 2013 Apr 25; 152(4):224-9, 246. PubMed ID: 23844525
    [Abstract] [Full Text] [Related]

  • 34. Occupational exposure of staff to HIV and prophylaxis therapy.
    Peate I.
    Br J Nurs; 2013 Apr 25; 13(19):1146-50. PubMed ID: 15573009
    [Abstract] [Full Text] [Related]

  • 35. Update: potential exposures to attenuated vaccine strain Brucella abortus RB51 during a laboratory proficiency test--United States and Canada, 2007.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Jan 18; 57(2):36-9. PubMed ID: 18199966
    [Abstract] [Full Text] [Related]

  • 36. Costs of management of occupational exposures to blood and body fluids.
    O'Malley EM, Scott RD, Gayle J, Dekutoski J, Foltzer M, Lundstrom TS, Welbel S, Chiarello LA, Panlilio AL.
    Infect Control Hosp Epidemiol; 2007 Jul 18; 28(7):774-82. PubMed ID: 17564978
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.